442 related articles for article (PubMed ID: 38009668)
1. Role of non-coding RNAs as new therapeutic targets in regulating the EMT and apoptosis in metastatic gastric and colorectal cancers.
Ebrahimi N; Hakimzadeh A; Bozorgmand F; Speed S; Manavi MS; Khorram R; Farahani K; Rezaei-Tazangi F; Mansouri A; Hamblin MR; Aref AR
Cell Cycle; 2023 Oct; 22(20):2302-2323. PubMed ID: 38009668
[TBL] [Abstract][Full Text] [Related]
2. Non-coding RNAs underlying chemoresistance in gastric cancer.
Poursheikhani A; Bahmanpour Z; Razmara E; Mashouri L; Taheri M; Morshedi Rad D; Yousefi H; Bitaraf A; Babashah S
Cell Oncol (Dordr); 2020 Dec; 43(6):961-988. PubMed ID: 32495294
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
4. Impact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer.
Yamaguchi K; Yamamoto T; Chikuda J; Shirota T; Yamamoto Y
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204785
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
Yang Y; Du Y; Liu X; Cho WC
Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
[TBL] [Abstract][Full Text] [Related]
6. Non‑coding RNAs that regulate the Wnt/β‑catenin signaling pathway in gastric cancer: Good cop, bad cop? (Review).
Shao Z; Gao D; Chen L; Ding W; Yu Q
Oncol Rep; 2020 Oct; 44(4):1314-1321. PubMed ID: 32945460
[TBL] [Abstract][Full Text] [Related]
7. Noncoding RNAs in inflammation and colorectal cancer.
Ma S; Long T; Huang WJM
RNA Biol; 2020 Nov; 17(11):1628-1635. PubMed ID: 31847691
[TBL] [Abstract][Full Text] [Related]
8. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
[TBL] [Abstract][Full Text] [Related]
9. Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs.
Lulli M; Napoli C; Landini I; Mini E; Lapucci A
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362222
[TBL] [Abstract][Full Text] [Related]
10. Competitive endogenous RNA networks: Decoding the role of long non-coding RNAs and circular RNAs in colorectal cancer chemoresistance.
Khalafizadeh A; Hashemizadegan SD; Shokri F; Bakhshinejad B; Jabbari K; Motavaf M; Babashah S
J Cell Mol Med; 2024 Apr; 28(7):e18197. PubMed ID: 38506091
[TBL] [Abstract][Full Text] [Related]
11. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer.
Tang XJ; Wang W; Hann SS
Biochimie; 2019 Aug; 163():58-72. PubMed ID: 31082429
[TBL] [Abstract][Full Text] [Related]
12. Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers.
Zabeti Touchaei A; Vahidi S; Samadani AA
Clin Exp Med; 2024 Jan; 24(1):29. PubMed ID: 38294554
[TBL] [Abstract][Full Text] [Related]
13. Role of non-coding RNAs as novel biomarkers for detection of colorectal cancer progression through interaction with the cell signaling pathways.
Esmaeili M; Keshani M; Vakilian M; Esmaeili M; Peymani M; Seyed Forootan F; Chau TL; Göktuna SI; Zaker SR; Nasr Esfahani MH; Ghaedi K
Gene; 2020 Aug; 753():144796. PubMed ID: 32450203
[TBL] [Abstract][Full Text] [Related]
14. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer.
Wang L; Cho KB; Li Y; Tao G; Xie Z; Guo B
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744051
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNAs as Biomarkers for Survival in Colorectal Cancer Patients.
Andrabi MQ; Kesavan Y; Ramalingam S
Curr Aging Sci; 2024; 17(1):5-15. PubMed ID: 36733201
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the functional landscape and therapeutic implications of noncoding RNAs in the TGF-β signaling pathway in colorectal cancer: A comprehensive review.
Saadh MJ; Allela OQB; Sattay ZJ; Al Zuhairi RAH; Ahmad H; Eldesoky GE; Adil M; Ali MS
Pathol Res Pract; 2024 Mar; 255():155158. PubMed ID: 38320438
[TBL] [Abstract][Full Text] [Related]
18. Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response.
Sadrkhanloo M; Entezari M; Rashidi M; Hashemi M; Raesi R; Saghari S; Daneshi S; Salimimoghadam S; Hushmandi K; Mirzaei S; Taheriazam A
Eur J Pharmacol; 2022 Oct; 932():175212. PubMed ID: 36055365
[TBL] [Abstract][Full Text] [Related]
19. Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways.
Sabouni E; Nejad MM; Mojtabavi S; Khoshduz S; Mojtabavi M; Nadafzadeh N; Nikpanjeh N; Mirzaei S; Hashemi M; Aref AR; Khorrami R; Nabavi N; Ertas YN; Salimimoghadam S; Zandieh MA; Rahmanian P; Taheriazam A; Hushmandi K
Biomed Pharmacother; 2023 Apr; 160():114395. PubMed ID: 36804124
[TBL] [Abstract][Full Text] [Related]
20. Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential.
Luo ZD; Wang YF; Zhao YX; Yu LC; Li T; Fan YJ; Zeng SJ; Zhang YL; Zhang Y; Zhang X
World J Gastroenterol; 2023 Jan; 29(1):1-18. PubMed ID: 36683709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
